Elizabeth Berry-Kravis is professor of child neurology at Rush University Medical Center in Chicago.
Elizabeth Berry-Kravis
Professor
Rush University Medical Center
From this contributor
Analysis offers new hope for failed fragile X drug
Eye tracking shows that mavoglurant, a once-abandoned experimental drug for fragile X syndrome, enters the brain and boosts social interest, says Elizabeth Berry-Kravis.
Analysis offers new hope for failed fragile X drug
Questions for Elizabeth Berry-Kravis: Dodging mouse traps
A mouse model of fragile X syndrome lacks a key feature of the condition, prompting researchers to look for other ways to test treatments.
Questions for Elizabeth Berry-Kravis: Dodging mouse traps
Questions for Elizabeth Berry-Kravis: Measuring drug effects
Drugs designed to treat fragile X syndrome have yet to show substantial benefits in people. But rather than abandon them, child neurologist Elizabeth Berry-Kravis suggests a new way to measure their effectiveness.
Questions for Elizabeth Berry-Kravis: Measuring drug effects
Explore more from The Transmitter
Transforming AI models into useful model organisms
These systems were not built to explain the brain. But treating them as model organisms that we can perturb and evolve will move us closer to that goal.
Transforming AI models into useful model organisms
These systems were not built to explain the brain. But treating them as model organisms that we can perturb and evolve will move us closer to that goal.
Cortical area remixes macaques’ knowledge blocks to solve new problems
When monkeys draw complex shapes, their neural activity reflects patterns of activation elicited by drawing simpler, component shapes.
Cortical area remixes macaques’ knowledge blocks to solve new problems
When monkeys draw complex shapes, their neural activity reflects patterns of activation elicited by drawing simpler, component shapes.
Getting grants feels good, but giving them is even better
As director of grants management at the Cure Alzheimer’s Fund, Kaela Singleton bets on bold science and shares in the joy of discovery.
Getting grants feels good, but giving them is even better
As director of grants management at the Cure Alzheimer’s Fund, Kaela Singleton bets on bold science and shares in the joy of discovery.